Related Experiment Video
Updated: Jul 5, 2025
Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
LINC00707 impairs the Natural Killer cell antitumour activity in hepatocellular carcinoma through decreasing YTHDF2
Mingwei Wei1,2,3, Libai Lu2, Jiasheng Ma2
1Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Abstract:
Hepatocellular carcinoma (HCC) is the fifth most frequently diagnosed cancer and ranks third in cancer-related fatalities. The recognized involvement of long noncoding RNAs (lncRNAs) in several cancer types, including HCC, inspired this study to explore a novel lncRNA's functional importance in the progression of HCC. To achieve this, lncRNA microarray analysis was conducted on three distinct sets of HCC tissues, revealing LINC00707 as the most significantly upregulated lncRNA. Further research into its biological functions has revealed that LINC00707 acts as an oncogene, driving HCC progression by enhancing the proliferation, migration and invasion of HCC cells. Mechanistic insights were provided, demonstrating that LINC00707 interacts with YTH N6-methyladenosine RNA-binding protein 2 (YTHDF2), thus facilitating the ubiquitination-dependent degradation of the YTHDF2 protein. Furthermore, LINC00707 was found to influence the cytotoxicity of NK-92MI cells against HCC cells through its interactions with YTHDF2. These findings significantly contribute to a deeper understanding of the role played by LINC00707 in the progression of HCC.
Insights
This study identifies LINC00707 as a key oncogene in hepatocellular carcinoma (HCC) progression. It promotes cancer growth and invasion by interacting with YTHDF2, impacting NK cell cytotoxicity.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern, ranking fifth in incidence and third in mortality.
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in various cancers, including HCC.
Purpose of the Study:
- To investigate the functional significance of a novel lncRNA, LINC00707, in the progression of hepatocellular carcinoma.
- To elucidate the molecular mechanisms underlying LINC00707's role in HCC development.
Main Methods:
- LncRNA microarray analysis of HCC tissues to identify differentially expressed lncRNAs.
- Functional assays to assess the impact of LINC00707 on HCC cell proliferation, migration, and invasion.
- Co-immunoprecipitation and Western blot analyses to investigate protein-RNA interactions and degradation pathways.
Main Results:
- LINC00707 was identified as the most significantly upregulated lncRNA in HCC tissues.
- LINC00707 functions as an oncogene, promoting HCC cell proliferation, migration, and invasion.
- LINC00707 interacts with YTH N6-methyladenosine RNA-binding protein 2 (YTHDF2), leading to YTHDF2 degradation and influencing NK cell cytotoxicity against HCC cells.
Conclusions:
- LINC00707 plays a critical role in promoting HCC progression through oncogenic mechanisms.
- The interaction between LINC00707 and YTHDF2 is a key pathway influencing HCC cell behavior and immune evasion.
- LINC00707 represents a potential therapeutic target for hepatocellular carcinoma treatment.
